Nbty Manufacturing

Wakunaga of America, Co., Ltd. is a privately held, family-owned health and wellness company that specializes in offering high-quality dietary supplements. With a commitment to promoting natural therapy for individual health, Wakunaga aims to empower health-conscious individuals to take control of their well-being and live their best lives. Driven by a dedication to quality and backed by scientific research, Wakunaga's family of brands, including Kyolic, Kyo-Green, Kyo-Dophilus, and Moducare, provide a range of products designed to support healthy living. With a focus on customer satisfaction and a mission to provide effective and reliable supplements, Wakunaga of America is a trusted name in the industry.Generated from the website

Established in 1940, Grifols USA develops and manufactures a variety of medical devices and diagnostic systems for the health care industry. It distributes products in the fields of transfusion, blood banking, clinical analysis and specialty therapy. The company provides plasma derivatives and blood coagulation analyzers. Its products are used for the treatment of oncology and pediatric dysfunctions, as well as offers solutions in the area of pain management. The company supplies products under the Gri-fill, Misterium, Alphanate, AlphaNine, Profilnine, Flebogamma, Triturus, Albutein and Human Albumin Grifols brands. It offers technical support, marketing, plasma screening, and research and development services. Grifols USA is a part of Grifols, S.A., which is a group of companies that serves health care professionals and patients in more than 90 countries worldwide.

CytRx Corporation is a biopharmaceutical company engaged in the development of high-value therapeutics utilizing its core technologies in small molecule drugs, RNAi drug discovery and DNA vaccines. RNAi has been shown to effectively silence a targeted disease-causing gene within a living cell. The technology uses ribonucleic acid to selectively turn off the harmful genes of infectious viruses or malignant tumor cells. The company s small molecule drug candidates provide cellular protection by activating molecular chaperone proteins that can repair or degrade proteins that are believed to cause many diseases. The company s research and development activities are focused on two of its technologies, FLOCOR, an intravenous agent for acute vaso-occlusive disorders and related acute care applications, and TRAXZFECT, a DNA delivery technology which may have wide applications in DNA vaccines and gene therapy. CytRx Corporation is headquartered in Los Angeles.